BioWorld Asia

Jan. 28, 2004

Two German Kinase Companies Merge, Bring In EUR11M Financing

MUNICH, Germany - Two young Munich biotechnology companies - Nadag AG and Sireen AG - merged to form Sirenade Pharmaceuticals AG, which will focus on oncology and central nervous system conditions. (BioWorld International) Read More

As GW's Sativex Is Reviewed, Extension-Study Data Grow

Detailed Inflammation Pathway Map To Hasten Drug Discovery

BresaGen Seeking Protection After Talks With Investor Fail

Denmark Eyes North Sea Oil Tax As Source For Research Funding

EU Aiming To Pave Way For Tissue-Engineering Market

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 8, 2026.

ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins

BioWorld

If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...

New York University identifies new analogues of mannose-6-phosphate

BioWorld Science

New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

Woman taking medication for mental illness

Autobahn on the fast track with bipolar thyroid agonist

BioWorld

Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...